Neil Portman 32nd Lorne Cancer 2020

Abstracts this author is presenting:

• Synergistic targeting of estrogen-receptor positive breast cancers by MDM2 inhibition in combination with endocrine therapy or CDK4/6 inhibition — Poster Session II